NEKTAR THERAPEUTICS — Director's Dealing 2016

Sep 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2016-09-23

Reporting Person: WHITFIELD ROY A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-23	Common Stock	M	15000	$5.15	Acquired	53000	Direct
2016-09-23	Common Stock	M	1000	$8.37	Acquired	54000	Direct
2016-09-23	Common Stock	M	30000	$5.14	Acquired	84000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-23	Stock Option	$5.15	M	15000	Disposed	2016-12-01	Common Stock (15000)	Direct
2016-09-23	Stock Option	$8.37	M	1000	Disposed	2017-09-14	Common Stock (1000)	Direct
2016-09-23	Stock Option	$5.14	M	30000	Disposed	2019-09-12	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20000	Indirect